Market Cap

Guangzhou Boji Medical & Biotechnological Co. Ltd Market Capitalization:

CN¥2.88 Billion

CNY as of July 1, 2024

US$396.9 Million

business Guangzhou Boji Medical & Biotechnological Co. Ltd Company Profile

Guangzhou Boji Medical & Biotechnological Co. Ltd Main Stock Listing

SZSE: 300404

Market Capitalization History of Guangzhou Boji Medical & Biotechnological Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Guangzhou Boji Medical & Biotechnological Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥3.38 B 15.72%
Jan. 1, 2023 CN¥2.92 B -2.92%
Jan. 1, 2022 CN¥3.01 B 7.61%
Jan. 1, 2021 CN¥2.80 B -19.30%
Jan. 1, 2020 CN¥3.47 B 114.87%
Jan. 1, 2019 CN¥1.61 B -35.39%
Jan. 1, 2018 CN¥2.50 B -45.35%
Jan. 1, 2017 CN¥4.57 B 3.12%
Jan. 1, 2016 CN¥4.43 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Guangzhou Boji Medical & Biotechnological Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Guangzhou Boji Medical & Biotechnological Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300404

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.